Sumar Biotech LLP
About Sumar Biotech LLP
Data last updated:
Sumar Biotech LLP is a limited liability partnership (LLP) based in Mehsana, Gujarat, India, recognised as a startup by DPIIT. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 30 January 2018 and has been in existence for over 8 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAL-8744. Its GSTIN is 24ADOFS9536L1ZA (Gujarat).
The LLP has a total obligation of contribution of ₹50 Lakh. It is led by designated partners including Jaimin Nitinkumar Patel and Tusharkumar Rameshbhai Patel.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Plot No. 112 To 114 GIDC At: – Gozariya, Mehsana, Gujarat, India – 382825.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹58.12 Cr. For the same year it recorded a net profit of ₹4.11 Cr (net margin 7.1%) and EBITDA of ₹10.06 Cr (EBITDA margin 17.3%). Revenue has grown at a compounded annual rate (CAGR) of 81% over three years.
The LLP has about 42 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹15 Cr on record. Court records list 3 cases involving the LLP, including 3 filed against it; 1 case is pending.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 112 To 114 GIDC At: – Gozariya, Mehsana, Gujarat, India – 382825
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Sumar Biotech LLP FY 2025 filings available
Sumar Biotech LLP reported revenue of ₹58.12 Cr for FY 2023.
Compounded Annual Growth Rate (CAGR) of Sumar Biotech LLP
Revenue has grown at a compounded annual rate (CAGR) of 81% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sumar Biotech LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | ₹58.12 Cr | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹4.11 Cr | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sumar Biotech LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 7.1% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Sumar Biotech are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Sumar Biotech LLP
Sumar Biotech has 3 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jaimin Nitinkumar Patel Also directs: Shivani Cotton Private Limited | Designated Partner | 02 Dec 2023 | 2 Years 10 Months | Current |
| Tusharkumar Rameshbhai Patel | Designated Partner | 30 Jan 2018 | 8 Years 8 Months | Current |
| Sunny Nitinkumar Patel | Designated Partner | 30 Jan 2018 | 8 Years 8 Months | Current |
Ownership and Shareholding of Sumar Biotech LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sumar Biotech LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Mar 2020 | Hdfc Bank Limited | ₹15 Cr | Open |
Total charge records: 1 View all charges
Legal Cases of Sumar Biotech LLP
Sumar Biotech LLP has 3 court cases on record: 3 filed against it. 1 case is pending and 2 are disposed. Status as checked between 29 Sep 2026 and 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by an individual | Pending |
| District court, Mahesana, Gujarat | Court case (DST-LC) | Filed against the company by an individual | Disposed |
| District court, RAJKOT, Gujarat | Motor accident claim | Filed against the company by an individual | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Sumar Biotech LLP
Sumar Biotech LLP has a workforce of 42 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sumar Biotech LLP
Sumar Biotech LLP has 5 designated partner changes on record since 2018: 3 appointments and 2 cessations. The latest: Jaimin Nitinkumar Patel was appointed as Designated Partner on 02 Dec 2023.
Credit Ratings, Litigation & Regulatory Alerts for Sumar Biotech LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sumar Biotech LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sumar Biotech LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sumar Biotech LLP
Sumar Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24ADOFS9536L1ZA | Gujarat | Active | 27 Mar 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sumar Biotech LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sumar Biotech LLP
Sumar Biotech is an active limited liability partnership based in Mehsana, Gujarat, India. The LLP works in api manufacturers, within the pharma industry. It was incorporated on 30 January 2018 (8+ years old) and is registered under LLPIN AAL-8744.
Sumar Biotech reported revenue of ₹58.12 Cr for FY 2023.
Sumar Biotech has 3 current designated partners:
- Jaimin Nitinkumar Patel - Designated Partner
- Tusharkumar Rameshbhai Patel - Designated Partner
- Sunny Nitinkumar Patel - Designated Partner
Sumar Biotech reported a net profit of ₹4.11 Cr (net margin 7.1%) and EBITDA of ₹10.06 Cr (EBITDA margin 17.3%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sumar Biotech is 81% over three years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sumar Biotech is 24ADOFS9536L1ZA, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Sumar Biotech is AAL-8744. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Sumar Biotech has 3 court cases on record: 3 filed against it. 1 is pending.
Sumar Biotech was incorporated on 30 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Jaimin Nitinkumar Patel was appointed as Designated Partner on 02 Dec 2023. Jaimin Nitinkumar Patel ceased to be Partner on 01 Dec 2023. Nirav Nalinkumar Vyas ceased to be Designated Partner on 16 Sep 2019. Sumar Biotech has 5 designated partner changes on record in total.